These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16740703)

  • 1. Epidermal growth factor receptor signaling is up-regulated in human colonic aberrant crypt foci.
    Cohen G; Mustafi R; Chumsangsri A; Little N; Nathanson J; Cerda S; Jagadeeswaran S; Dougherty U; Joseph L; Hart J; Yerian L; Tretiakova M; Yuan W; Obara P; Khare S; Sinicrope FA; Fichera A; Boss GR; Carroll R; Bissonnette M
    Cancer Res; 2006 Jun; 66(11):5656-64. PubMed ID: 16740703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor receptor controls flat dysplastic aberrant crypt foci development and colon cancer progression in the rat azoxymethane model.
    Dougherty U; Sehdev A; Cerda S; Mustafi R; Little N; Yuan W; Jagadeeswaran S; Chumsangsri A; Delgado J; Tretiakova M; Joseph L; Hart J; Cohen EE; Aluri L; Fichera A; Bissonnette M
    Clin Cancer Res; 2008 Apr; 14(8):2253-62. PubMed ID: 18413814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
    Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
    J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
    Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of early and intermediate stages of colon cancer by targeting multiple members of the EGFR family with EGFR-related protein.
    Schmelz EM; Xu H; Sengupta R; Du J; Banerjee S; Sarkar FH; Rishi AK; Majumdar AP
    Cancer Res; 2007 Jun; 67(11):5389-96. PubMed ID: 17545620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor signaling is required for microadenoma formation in the mouse azoxymethane model of colonic carcinogenesis.
    Fichera A; Little N; Jagadeeswaran S; Dougherty U; Sehdev A; Mustafi R; Cerda S; Yuan W; Khare S; Tretiakova M; Gong C; Tallerico M; Cohen G; Joseph L; Hart J; Turner JR; Bissonnette M
    Cancer Res; 2007 Jan; 67(2):827-35. PubMed ID: 17234795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans.
    Rosenberg DW; Yang S; Pleau DC; Greenspan EJ; Stevens RG; Rajan TV; Heinen CD; Levine J; Zhou Y; O'Brien MJ
    Cancer Res; 2007 Apr; 67(8):3551-4. PubMed ID: 17440063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of PPARbeta/delta and cyclin D1 in flat dysplastic ACF and adenomas in Apc(Min/+) mice.
    Knutsen HK; Olstørn HB; Paulsen JE; Husøy T; Goverud IL; Løberg EM; Kristiansen K; Alexander J
    Anticancer Res; 2005; 25(6B):3781-9. PubMed ID: 16309164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis.
    Takahashi M; Mutoh M; Kawamori T; Sugimura T; Wakabayashi K
    Carcinogenesis; 2000 Jul; 21(7):1319-27. PubMed ID: 10874009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancer.
    Nambiar PR; Nakanishi M; Gupta R; Cheung E; Firouzi A; Ma XJ; Flynn C; Dong M; Guda K; Levine J; Raja R; Achenie L; Rosenberg DW
    Cancer Res; 2004 Sep; 64(18):6394-401. PubMed ID: 15374946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis.
    Yamada Y; Yoshimi N; Hirose Y; Kawabata K; Matsunaga K; Shimizu M; Hara A; Mori H
    Cancer Res; 2000 Jul; 60(13):3323-7. PubMed ID: 10910031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant increase in cell proliferation.
    Otori K; Sugiyama K; Hasebe T; Fukushima S; Esumi H
    Cancer Res; 1995 Nov; 55(21):4743-6. PubMed ID: 7585496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1.
    Bissonnette M; Khare S; von Lintig FC; Wali RK; Nguyen L; Zhang Y; Hart J; Skarosi S; Varki N; Boss GR; Brasitus TA
    Cancer Res; 2000 Aug; 60(16):4602-9. PubMed ID: 10969813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
    Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
    Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant crypt foci.
    Alrawi SJ; Schiff M; Carroll RE; Dayton M; Gibbs JF; Kulavlat M; Tan D; Berman K; Stoler DL; Anderson GR
    Anticancer Res; 2006; 26(1A):107-19. PubMed ID: 16475686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursodeoxycholic acid inhibits Ras mutations, wild-type Ras activation, and cyclooxygenase-2 expression in colon cancer.
    Khare S; Cerda S; Wali RK; von Lintig FC; Tretiakova M; Joseph L; Stoiber D; Cohen G; Nimmagadda K; Hart J; Sitrin MD; Boss GR; Bissonnette M
    Cancer Res; 2003 Jul; 63(13):3517-23. PubMed ID: 12839936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mutations of APC and K-ras gene in aberrant crypt foci from human colon].
    Yuan P; Sun M; Zhang J; Zhu X; Shi D
    Zhonghua Bing Li Xue Za Zhi; 2001 Feb; 30(1):35-8. PubMed ID: 11866955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of K-ras mutations in azoxymethane-induced aberrant crypt foci in mice using LNA-mediated real-time PCR clamping and mutant-specific probes.
    Hu Y; Le Leu RK; Young GP
    Mutat Res; 2009; 677(1-2):27-32. PubMed ID: 19442760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of cyclin D1 and cyclin E in 1,2-dimethylhydrazine dihydrochloride-induced rat colon carcinogenesis.
    Hur K; Kim JR; Yoon BI; Lee JK; Choi JH; Oh GT; Kim DY
    J Vet Sci; 2000 Dec; 1(2):121-6. PubMed ID: 14614307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K-ras and p53 mutations in human colorectal aberrant crypt foci.
    Losi L; Roncucci L; di Gregorio C; de Leon MP; Benhattar J
    J Pathol; 1996 Mar; 178(3):259-63. PubMed ID: 8778329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.